Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Spindox S.P.A ( (IT:SPN) ) has shared an announcement.
Spindox Labs, the R&D center of Spindox S.p.A, coordinated the REXASI-PRO project, aimed at developing autonomous and reliable wheelchairs for people with reduced mobility. The project, funded by the European Commission, concluded with a General Assembly in Rome, showcasing advancements in AI frameworks and social robotic navigation systems. This initiative highlights Spindox’s commitment to integrating scientific rigor with social impact, paving the way for new applications in autonomous mobility and human-robot interoperability.
The most recent analyst rating on (IT:SPN) stock is a Buy with a EUR15.80 price target. To see the full list of analyst forecasts on Spindox S.P.A stock, see the IT:SPN Stock Forecast page.
More about Spindox S.P.A
Spindox S.p.A operates in the information technology market, focusing on supporting client innovation through technological consulting, industrial research, and product offerings. The company is involved in areas such as IT Strategy and Governance, User Centric Experience, Data Intelligence, and Emerging Technologies. With a CAGR of 25.5% from 2021 to 2023, Spindox is one of the fastest-growing companies in its sector, employing 1,300 people across Italy and four international branches.
Average Trading Volume: 8,471
Technical Sentiment Signal: Buy
Current Market Cap: €74.71M
Learn more about SPN stock on TipRanks’ Stock Analysis page.